These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38711112)

  • 1. Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing - a randomised controlled trial.
    Olsen MT; Klarskov CK; Pedersen-Bjergaard U; Hansen KB; Kristensen PL
    BMC Endocr Disord; 2024 May; 24(1):60. PubMed ID: 38711112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.
    Klarskov CK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
    Trials; 2020 Nov; 21(1):968. PubMed ID: 33239100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen.
    Gómez AM; Umpierrez GE; Muñoz OM; Herrera F; Rubio C; Aschner P; Buendia R
    J Diabetes Sci Technol; 2015 Aug; 10(2):325-9. PubMed ID: 26330394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial.
    Idrees T; Castro-Revoredo IA; Oh HD; Gavaller MD; Zabala Z; Moreno E; Moazzami B; Galindo RJ; Vellanki P; Cabb E; Johnson TM; Peng L; Umpierrez GE
    J Am Med Dir Assoc; 2024 May; 25(5):884-888. PubMed ID: 38460943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus.
    Colunga-Lozano LE; Gonzalez Torres FJ; Delgado-Figueroa N; Gonzalez-Padilla DA; Hernandez AV; Roman Y; Cuello-García CA
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011296. PubMed ID: 30488948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya.
    Marbán-Castro E; Muhwava L; Kamau Y; Safary E; Rheeder P; Karsas M; Kemp T; Freitas J; Carrihill M; Dave J; Katambo D; Kimetto J; Allie R; ; ; Ndungu J; Sigwebela N; Akach D; Girdwood S; Erkosar B; Nichols BE; Haldane C; Vetter B; Shilton S
    Trials; 2024 May; 25(1):331. PubMed ID: 38773658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
    Martens T; Beck RW; Bailey R; Ruedy KJ; Calhoun P; Peters AL; Pop-Busui R; Philis-Tsimikas A; Bao S; Umpierrez G; Davis G; Kruger D; Bhargava A; Young L; McGill JB; Aleppo G; Nguyen QT; Orozco I; Biggs W; Lucas KJ; Polonsky WH; Buse JB; Price D; Bergenstal RM;
    JAMA; 2021 Jun; 325(22):2262-2272. PubMed ID: 34077499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial.
    Boom DT; Sechterberger MK; Rijkenberg S; Kreder S; Bosman RJ; Wester JP; van Stijn I; DeVries JH; van der Voort PH
    Crit Care; 2014 Aug; 18(4):453. PubMed ID: 25139609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial.
    Klarskov CK; Windum NA; Olsen MT; Dungu AM; Jensen AK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
    Diabetes Technol Ther; 2022 Feb; 24(2):102-112. PubMed ID: 34524009
    [No Abstract]   [Full Text] [Related]  

  • 11. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a hybrid protocol using continuous glucose monitoring and point-of-care testing in non-critically ill patients in a community hospital.
    Baker M; Lauterwasser S; Valenti C; Kallenberger M; Stolte H
    Am J Health Syst Pharm; 2024 Apr; 81(9):e261-e267. PubMed ID: 38146957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittently scanned continuous glucose monitoring provides no benefit over structured self-monitoring of blood glucose in type 2 diabetes not on prandial insulin, in the context of diabetes self-management education: GLucose monitoring programme SingaporE (GLiMPSE).
    Rama Chandran S; Rahman N; Gandhi M; Tan NC; Phoon IKY; Seah DEJ; Cheah MH; Sek K; Gardner DS
    Diabetes Res Clin Pract; 2024 May; 211():111678. PubMed ID: 38642860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit.
    Ang L; Lin YK; Schroeder LF; Huang Y; DeGeorge CA; Arnold P; Akanbi F; Knotts S; DuBois E; Desbrough N; Qu Y; Freeman R; Esfandiari NH; Pop-Busui R; Gianchandani R
    J Diabetes Sci Technol; 2024 May; 18(3):562-569. PubMed ID: 38563491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peer support for adults with type 2 diabetes starting continuous glucose monitoring-An exploratory randomised controlled trial.
    Lind N; Christensen MB; Hansen DL; Willaing I; Nørgaard K
    Diabet Med; 2024 Jun; 41(6):e15321. PubMed ID: 38576173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.
    de Portu S; Vorrink L; Re R; Shin J; Castaneda J; Habteab A; Cohen O
    BMJ Open; 2022 Feb; 12(2):e050635. PubMed ID: 35110310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice.
    Furler J; O'Neal DN; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Browne JL; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins AJ; Liew D; Clarke P; Best J
    BMJ Open; 2018 Jul; 8(7):e021435. PubMed ID: 30018097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.
    Pasquel FJ; Gianchandani R; Rubin DJ; Dungan KM; Anzola I; Gomez PC; Peng L; Hodish I; Bodnar T; Wesorick D; Balakrishnan V; Osei K; Umpierrez GE
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):125-133. PubMed ID: 27964837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.